DATA ANALYSIS

Big data: the opportunity to think outside the discipline

Article metrics

EULAR has published points to consider for the use of big data in rheumatology research that open up discussions and debates that are necessary and important, but are they missing the opportunities presented by cross-discipline collaboration to expand our perspective of disease beyond what is clinically visible?

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Gossec, L. et al. EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2019-215694 (2019).

  2. 2.

    Tedeschi, S. K. et al. Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration. Arthritis Care Res. 4, 571–581 (2016).

  3. 3.

    ELIXIR. ELIXIR Data Platform. Elixir-europe.org https://www.elixir-europe.org/platforms/data (2017).

  4. 4.

    Kinkorová, J. & Topolcˇan, O. Biobanks in Horizon 2020: sustainability and attractive perspectives. EPMA J. 9, 345–353 (2018).

  5. 5.

    Barturen, G. et al. Moving towards a molecular taxonomy of autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 14, 75–93 (2018).

  6. 6.

    Innovative Medicines Initiative. Immune diseases and machine learning feature in new IMI Call for proposals. Imi.europa.eu https://www.imi.europa.eu/news-events/press-releases/immune-diseases-and-machine-learning-feature-new-imi-call-proposals (2018).

Download references

Acknowledgements

The work of the author has been supported by the Fundación Pública Andaluza Progreso y Salud.

Author information

Correspondence to Marta E. Alarcón-Riquelme.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article